XOSPATA (gilteritinib) tablets is used for the treatment of patients with Acute Myeloid Leukemia.

Xospata (gilteritinib) is a prescription medicine used to treat acute myeloid leukemia (AML) in adults with an abnormal FLT3 gene. Your doctor will test you for this gene. Xospata is given after other cancer treatments did not work or have stopped working.

XOSPATA (gilteritinib) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of XOSPATA (gilteritinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the XOSPATA (gilteritinib) tablets medicine cost price in India.

The order for XOSPATA (gilteritinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Gilteritinib (trade name Xospata) is an anti-cancer drug. It acts as an inhibitor of AXL receptor tyrosine kinase, hence it is a tyrosine kinase inhibitor.

  • It was developed by Astellas Pharma. In April 2018, Astellas filed a new drug application with the Food and Drug Administration for gilteritinib for the treatment of adult patients with FLT3 mutation–positive relapsed or refractory acute myeloid leukemia (AML). In November 2018, the FDA approved gilteritinib for treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. The recommended dose of gilteritinib is 120 mg orally once daily. Gilteritinib was granted orphan drug status by the U.S. FDA, the European Commission (EC) and the Japan Ministry of Health, Labor and Welfare, for some AML patients.

  • Gilteritinib is used to treat a certain type of acute myeloid leukemia (AML) that has worsened or returned after treatment with other chemotherapy medications. Gilteritinib is in a class of medications called kinase inhibitors.
  • XOSPATA (gilteritinib) tablets for oral use Initial U.S. Approval: 2001

    Generic Name: gilteritinib

    XOSPATA (gilteritinib

    XOSPATA™ (gilteritinib) for injection, for intravenous use is available.

    Get In Touch

    XOSPATA (gilteritinib) tablets suppliers in India

    IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand XOSPATA (gilteritinib) tablets on prescription and Import License in Patient's Name only.

    For overseas patients, XOSPATA (gilteritinib) tablets can be made available in Send your enquiry to find XOSPATA (gilteritinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for XOSPATA (gilteritinib).

    For XOSPATA (gilteritinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

    Lupin in alliance with Natco receives FDA approval for gilteritinib Tablets For More Details

    First Generic Version of XOSPATA Approved by FDA For More Details

    IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
    Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur